Dashenlin Pharm Grp Co Ltd (603233) — Cash Flow-to-Debt Ratio
Dashenlin Pharm Grp Co Ltd (603233) has a Cash Flow-to-Debt Ratio of 0.05x as of September 2025, meaning its operating cash flow of CN¥818.72 Million could theoretically repay 0% of its total liabilities (CN¥17.59 Billion) in one year. Check 603233 total capital reinvestment ratio to assess the company's total reinvestment commitment from operating cash flow.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Dashenlin Pharm Grp Co Ltd Cash Flow-to-Debt Ratio (2012–2025)
Historical debt coverage capacity for Dashenlin Pharm Grp Co Ltd across 14 annual periods. Also explore balance sheet size of Dashenlin Pharm Grp Co Ltd for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for Dashenlin Pharm Grp Co Ltd (2012–2025)
Year-by-year debt coverage analysis for Dashenlin Pharm Grp Co Ltd. For market capitalisation and broader financial context, see 603233 stock market capitalisation.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.30x | CN¥5.35 Billion | CN¥17.83 Billion | ▲ +76.8% |
| 2024 | 0.17x | CN¥3.11 Billion | CN¥18.30 Billion | ▼ -13.4% |
| 2023 | 0.20x | CN¥3.17 Billion | CN¥16.19 Billion | ▼ -27.1% |
| 2022 | 0.27x | CN¥3.76 Billion | CN¥13.98 Billion | ▲ +97.0% |
| 2021 | 0.14x | CN¥1.55 Billion | CN¥11.40 Billion | ▼ -52.8% |
| 2020 | 0.29x | CN¥1.95 Billion | CN¥6.76 Billion | ▼ -26.5% |
| 2019 | 0.39x | CN¥1.71 Billion | CN¥4.34 Billion | ▲ +55.4% |
| 2018 | 0.25x | CN¥873.64 Million | CN¥3.45 Billion | ▲ +19.4% |
| 2017 | 0.21x | CN¥640.39 Million | CN¥3.02 Billion | ▼ -4.2% |
| 2016 | 0.22x | CN¥495.60 Million | CN¥2.24 Billion | ▼ -22.6% |
| 2015 | 0.29x | CN¥468.59 Million | CN¥1.64 Billion | ▲ +14.2% |
| 2014 | 0.25x | CN¥448.58 Million | CN¥1.79 Billion | ▼ -5.2% |
| 2013 | 0.26x | CN¥288.22 Million | CN¥1.09 Billion | ▼ -43.8% |
| 2012 | 0.47x | CN¥289.31 Million | CN¥615.39 Million | — |